Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Colirio para el tratamiento de retinopatía diabética

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Fundación Innov. y Prosp. Salud en España - FIPSE
Funding: 25000
Reference: 060026/14
Duration: 15/02/2015 - 14/11/2015

Desarrollo de un tratamiento tópico (colirio) para la retinopatía diabética basado en la señalización de la vía del GLP-1

IP: Rafael Simó Canonge
Collaborators: Cristina Hernández Pascual, Patricia Bogdanov Baruj
Funding agency: Instituto de Salud Carlos III
Funding: 177100
Reference: DTS15/00151
Duration: 01/01/2016 - 30/06/2018

European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR). Neurodegeneration as an early event in the Pathogenesis of Diabetic Retinopathy: A multicentric, prospective, phase II-III, open randomized controlled trial to assess the e

IP: Rafael Simó Canonge
Collaborators: Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 30000
Reference: INT15/00126
Duration: 01/01/2016 - 31/12/2016

MOPEAD: Models Of Patient Engagement for Alzheimer’s Disease

IP: Rafael Simó Canonge
Collaborators: Cristina Hernández Pascual
Funding agency: The Innovative Medicines Initiative
Funding: 79887.5
Reference: MOPEAD_IMI2015
Duration: 01/09/2016 - 31/12/2019

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

José Luis Peiró Ibáñez

José Luis Peiró Ibáñez

Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Héctor Carmona Díez

Héctor Carmona Díez

Research assistant
Clinical Pharmacology
Read more
Laura Costa Comellas

Laura Costa Comellas

Predoctoral researcher
Pediatric Neurology
Read more
Javier Sánchez López

Javier Sánchez López

Research technician
Research Group on Status Epilepticus and Acute Seizures
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.